ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 4.430
+0.650 (17.20%)
At close: Mar 6, 2026
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 1.91 billion as of March 6, 2026. Its market cap has decreased by -14.98% in one year.
Market Cap
1.91B
Enterprise Value
1.31B
Revenue
134.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.43
Market Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 1.91B, a decrease of -73.76%. That is a compound annual growth rate of -41.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.91B | -24.01% |
| Dec 31, 2025 | 2.52B | 19.70% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
| Sep 5, 2023 | 7.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Frontage Holdings | 2.19B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.99B |
| Zhaoke Ophthalmology | 1.70B |
| Mabpharm | 1.67B |
| Cutia Therapeutics | 1.59B |
| Immunotech Biopharm | 1.48B |
| Kintor Pharmaceutical | 1.42B |
| CANbridge Pharmaceuticals | 1.40B |